Table 1.
Cancer | Circular RNA | Regulation of the expression in cancer | Genetic target (s) | Effect (s) | Model used | Sample type | Reference |
---|---|---|---|---|---|---|---|
GC | CiRS-7 | Up | miR-7 | Increase the overall survival | In vitro |
Tissue, cell line |
|
Circ_104,916 | Down | Unknown | Promote TNM and lymph node metastasis | In vitro |
Tissue, cell line |
[36] | |
Circ_0000181 | Down | Unknown | Lymphatic metastasis and distal metastasis | In vitro | Tissues, plasma | [37] | |
BLC | CircHIPK3 | Down | miR-558 | Promote Vascular invasion and lymph node metastasis | In vitro, In vivo |
Tissue, Cell line mice |
[38] |
CircTCF25 | Up |
miR-103a miR-107 CDK6 |
Promote cell proliferation, Migration |
In vitro | Tissue, Cell line | [39] | |
CircRNA BCRC4 | Down | miR-101 | Association with cell apoptosis | In vitro | Tissue, Cell line | [40] | |
ESCC | Circ-ITCH | Down | miR-7 miR-17 miR-214 | Inhibit the Wnt/β-catenin pathway | In vitro, In vivo |
Tissue, Cell line |
[41] |
hsa_circ_0067934 | Up | Unknown | Promote the proliferation and migration | In vitro | Tissue, cell line | [42] | |
circ-DLG 1 | Up |
miR-515 miR-942 miR-589 miR-136 |
Promote the esophageal cell proliferation ability | In vitro |
Tissue, cell line, Plasma |
[43] | |
BC | hsa_circ_0001982 | Up | miR-143 | Promote the proliferation and invasion and suppress apoptosis | In vitro |
Cell line, Tissue |
[44] |
CircMYO9B | Up | miR-4316 | Promote the BC cell proliferation, migration and invasion, upregulation of FOXP4 | In vitro, In vivo |
Tissue, Cell line |
[45] | |
hsa_circ_0007534 | Up | miR-593 | Promote the BC cell proliferation, colony formation, and invasion, upregulation of Mucin 19 (MUC19) | In vitro |
Tissue, Cell line |
[46] | |
CRC | CircITGA7 | Down | miR-370-3p | Promote the proliferation and metastasis in CRC cells via Ras pathway | In vitro, In vivo |
Tissues, cell line |
[47] |
hsa_circ_0000523 | Down | miR-31 | Promote the proliferation and suppressed apoptosis of CRC cells via indirectly regulating Wnt/β-catenin signaling pathway | In vitro, In vivo |
Tissues, cell line |
[48] | |
Circ-001569 | Up | miR-145 | Promote the proliferation, cell growth and invasion of CRC | In vitro |
Tissues, cell line |
||
HCC | CSMARCA5 | Down |
miR-17-3p miR-181b-5p |
Promote the growth and metastasis of HCC | In vitro, In vivo |
Tissues, cell line |
[49] |
CircMTO1 | Down | miR-9 | Promote the HCC progression and cell growth via miR9-P21 | In vitro, In vivo |
Tissues, cell line |
||
Circ_100,338 | Up | miR-141-3p | Promote the lung metastasis, vascular invasion, and TNM | In vitro, In vivo |
Tissues, cell line |
[50] | |
OSCC | CircRNA_100290 | Up | miR-29b | Suppress G1/S arrest, induce cell proliferation and upregulate the expression of CDK6 | In vitro, In vivo |
Tissues, cell line |
[51] |
hsa_circ_0055538 | Down |
p53/Bax/Apaf1/ caspase-3/ p21/Bcl2 |
Development of OSCC via the p53/Bcl-2/caspase signaling pathway. | In vitro, In vivo |
Tissues, Cell line |
[52] | |
CircDOCK1 | Up | miR-196a-5p | Inhibit the cell apoptosis via miR-196a-5p/BIRC3 pathway | In vitro, In vivo |
Tissues, Cell line |
[53] | |
PCa | Circ-SMARCA5 | Up | Unknown | Promote the cell cycle and inhibited cell apoptosis | In vitro | Cell line | [54] |
Circ-102,004 | Up | ERK/JNK/ Hedgehog | Promote the cell proliferation and decrease cell apoptosis in PCa | In vitro, In vivo |
Tissues, Cell line |
[55] | |
CircMYLK | Up | MiR-29a | Promote the PCa cell proliferation, invasion, and migration | In vitro |
Tissue, Cell line |
[56] | |
LC | Circ_100876 | Up | Unknown | Promote the lymph node metastasis/TNM and overall survival | In vitro | Tissues | [57] |
CircFARSA | Up |
miR-330-5p miR-326 FASN |
Promote the cell migration and invasion |
In vitro, In silico |
Tissue, Plasma |
[58] | |
CircRNF13 | Down | miR-93-5p | Inhibit the cell invasion and metastasis | In vitro |
Tissues, Cell line |
[59] | |
OS | hsa_circ_0001564 | Up | miR-29c-3p | Promote the proliferation activity, repressed cell cycle arrest in G0/G1 phase, and suppressed apoptosis | In vitro |
Tissues, Cell line |
[60] |
circ-0016347 | Up | miR-214 | Promote the proliferation, invasion and metastasis | In vitro, In vivo | Tissues, Cell line | [61] | |
circUBAP2 | Up | miR-143 | Promote the osteosarcoma growth and inhibit the apoptosis, and promote the osteosarcoma progression | In vitro, In vivo | Tissues, Cell line | [62] |
BC Breast Cancer, BLC Bladder cancer, CRC Colorectal Cancer, GC Gastric Cancer, ESCC Esophageal squamous cell carcinoma, LC Lung Cancer, OSCC Oral squamous cell carcinoma, HCC Hepatocellular carcinoma, OS Osteosarcoma, PCa Prostate cancer, TNM tumor-node-metastasis, EMT epithelial-mesenchymal transition